Q-Line Biotech Limited Share Price & Stock Analysis

Q-Line Biotech Limited (NSE: QLINE) is a Lucknow, Uttar Pradesh-based company in the Medical Consumables industry. With a market capitalisation of ₹1,280 Cr, it ranks #1,462 by market cap among the 6,197 Indian listed companies on FinBizNet, and #3 of 14 in Medical Consumables. The share price was ₹557.05 as of 19 Nov 2026.

Key Metrics

Current Price₹557.05
Market Cap₹1,280 Cr
NSE SymbolQLINE
SectorHealth Care > Health Care Equipment and Services > Health Care Equipment and Supplies
Sub-IndustryHealth Care Supplies > Medical Consumables
P/E Ratio15.7
Return on Equity22.63%
Return on Assets11.76%
Beta (1Y)1.15
HeadquartersLucknow, Uttar Pradesh
Websiteqlinebiotech.com

Shareholding and Delivery

Promoters held 67.51% of Q-Line Biotech Limited's shares as of Sept 2026, unchanged from May 2026.

About Q-Line Biotech Limited

Q-Line Biotech Limited develops, manufactures, and markets various reagents and consumables in India and internationally. It offers reagent kits, rapid cards, consumables, and point-of-care strips for applications in immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, and others, as well as in vitro testing of human samples, supporting disease prediction, prevention, diagnosis, monitoring, and health status evaluation. The company also provides diagnostic equipment comprising analyzers, point-of-care devices, and other critical components for diagnostic procedures; medical equipment maintenance services; and trades in macro cuvettes with balls, lab plastic plates, laboratory plastic tip rack, syringe pumps, and other consumables. In addition, it offers Selectra Pro M, an automatic clinical chemistry analyzer. Further, the company develops Selectra Pro XL, an automatic clinical chemistry analyzer for large laboratories and hospital networks; Mircolab 300, a semi-au

Products and Services

1. Manufacturing-This segment develops, manufactures, and markets various reagents and consumables. 2. Trading-This segment trades in macro cuvettes with balls, lab plastic plates, laboratory plastic tip rack, syringe pumps, and other consumables. 3. Other Unallocable Assets-NA 4. NA-NA

Business Segments

1. Manufacturing-67.4% 2. Trading-32.6%

Q-Line Biotech Limited vs Peers — Medical Consumables

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Poly Medicure Ltd.₹17,162 Cr53.310.84%₹581 Cr-14.5%
Sahajanand Medical Technologies₹4,899 Cr77.9—₹373 Cr—
Q-Line Biotech Limited₹1,280 Cr15.722.63%——
Laxmi Dental Limited₹1,128 Cr39.312.77%₹80 Cr-38.2%
Prevest Denpro Ltd₹502 Cr24.617.79%—-22.6%
Choksi Imaging Ltd.₹119 Cr22.313.51%—+94.0%
GSM Foils Limited₹72 Cr3.937.54%₹97 Cr-78.3%
Mohini Health & Hygiene Ltd₹51 Crn/m-17.18%—-41.2%
KMS Medisurgi Limited₹46 Cr188.4——+4.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Q-Line Biotech Limited?

Q-Line Biotech Limited is trading at ₹557.05, with a market capitalisation of ₹1,280 Cr.

Which sector does Q-Line Biotech Limited belong to?

Q-Line Biotech Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).

What are the key financial ratios of Q-Line Biotech Limited?

Q-Line Biotech Limited has a P/E of 15.7 and a return on equity of 22.63%.

What is the stock symbol of Q-Line Biotech Limited?

Q-Line Biotech Limited is listed on the NSE under the symbol QLINE.

What is the promoter holding in Q-Line Biotech Limited?

Promoters held 67.51% of Q-Line Biotech Limited's shares as of Sept 2026, unchanged from May 2026.

More on FinBizNet

Data as of 19 Nov 2026. Descriptive market data only — not investment advice.